Long-term Outcomes after the Discontinuation of Anti-Tumor Necrosis Factor-α Therapy in Patients with Inflammatory Bowel Disease under Clinical Remission: A Korean Association for the Study of Intestinal Disease Multicenter Study-Reference-Cited by-同舟云学术

Long-term Outcomes after the Discontinuation of Anti-Tumor Necrosis Factor-α Therapy in Patients with Inflammatory Bowel Disease under Clinical Remission: A Korean Association for the Study of Intestinal Disease Multicenter Study

Published:2021-09-15 Issue:5 Volume:15 Page:752-762
ISSN:1976-2283
Container-title:Gut and Liver
language:en
Short-container-title:Gut and Liver

Author:

Song Joo Hye¹^ORCID,Kang Eun Ae²^ORCID,Park Soo-Kyung³^ORCID,Hong Sung Noh¹^ORCID,Kim You Sun⁴^ORCID,Bang Ki Bae⁵^ORCID,Kim Kyeong Ok⁶^ORCID,Lee Hong Sub⁷^ORCID,Kang Sang-Bum⁸^ORCID,Shin Seung Yong⁹^ORCID,Song Eun Mi¹⁰^ORCID,Im Jong Pil¹¹^ORCID,Choi Chang Hwan⁹^ORCID,

Affiliation:

1. Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

2. Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea

3. Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea

4. Department of Internal Medicine, Seoul Paik Hospital, Inje University College of Medicine, Seoul, Korea

5. Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Korea

6. Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea

7. Department of Internal Medicine, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan, Korea

8. Department of Internal Medicine, Daejeon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Daejeon, Korea

9. Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea

10. Department of Internal Medicine, Ewha Womans University Seoul Hospital, Ewha Womans University School of Medicine, Seoul, Korea

11. Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea

Publisher

The Editorial Office of Gut and Liver

Subject

Gastroenterology,Hepatology

Link

http://pdf.medrang.co.kr/GNL/2021/015/GNL015-05-752.pdf

Reference36 articles.

1. Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis

2. Current new challenges in the management of ulcerative colitis

3. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn’s disease

4. Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped

5. Risk of incident Mycobacterium tuberculosis infection in patients with inflammatory bowel disease: a nationwide population-based study in South Korea

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mucosal Immunity and Trained Innate Immunity of the Gut;Gastroenterology Insights;2024-08-02

2. Challenges in IBD Research 2024: Precision Medicine;Inflammatory Bowel Diseases;2024-05-01

3. Krill Oil and Its Bioactive Components as a Potential Therapy for Inflammatory Bowel Disease: Insights from In Vivo and In Vitro Studies;Biomolecules;2024-04-06

4. Active flare of IgA nephropathy during long-term therapy with anti-tumor necrosis factor-α antibody drugs for Crohn’s disease: three case reports and literature review;CEN Case Reports;2023-11-30

5. Suboptimal Outcomes and Retreatment Rate of Patients With Crohn's Disease After Forced Discontinuation of Biologics: A Nationwide Population‐Based Study;Clinical Pharmacology & Therapeutics;2023-08-16